SEP 19, 2017 2:59 PM PDT

Melatonin Could Ease Chemo Pains

WRITTEN BY: Xuan Pham

Image credit: Pixabay.com

A common over-the-counter drug that pilots often take to alleviate jetlag may also help cancer patients ease the pain from chemotherapy.

According to a new study from the University of Edinburg, the drug melatonin blocks the pain signals from chemo-damaged nerve cells in rats.

The findings were based on research on a common condition known as chemotherapy-induced neuropathic pain (CINP). Patients suffering from this condition often report tingling and sensitivity to hot and cold temperatures. It’s thought that the chemotherapy agents damage nerve cells, causing such painful sensations.

In animal studies, researchers found that melatonin had the best effect if given before chemotherapy. That is, if given prior to the start of chemotherapy, nerve damage is reduced. If given after CINP has already developed, melatonin seemed to be ineffective. This suggest that melatonin is more of a preventative therapy for CINP, rather than a curative one.  

"These results are promising, especially as melatonin treatment is known to be safe in other conditions. However, more work will need to be done before we know if melatonin will help prevent pain in cancer patients undergoing chemotherapy,” said Dr. Helen Galley, a professor at the Institute of Medical Sciences at the University of Aberdeen, and the study’s co-lead author. It’s not entirely clear how melatonin reduces nerve damage from chemotherapy.

Under normal conditions, the body produces melatonin at night to prepare us for rest and sleep. Synthetic version of melatonin also exist and function in a similar fashion. In the US, the drug is available over the counter, but in some other countries, a prescription is required.

"We are actively exploring an early-phase clinical study to see if these exciting laboratory findings might translate to direct benefit for patients undergoing chemotherapy. This is an area of real unmet need, where new therapies are urgently required,” said Dr. Lesley Colvin, a pain specialist at the University of Edinburgh, and a study co-author.

It’s estimated that CINP affects nearly 70 percent of cancer patients undergoing chemotherapy. The condition can worsen the quality of life for patients undergoing treatment. Furthermore, CINP can persist in some patients even after chemotherapy. As such, finding a drug that can reduce the occurrence of this condition would benefit patients and caregivers.

"CINP can have a devastating impact on patients, and may limit chemotherapy doses, with potentially serious consequences. These findings are very exciting and suggest that melatonin could prevent CINP by protecting nerve cell mitochondria. Our next steps will be to further test this theory by looking at the effect of melatonin in other pain conditions that also involve mitochondrial damage,” said Dr. Carole Torsney, the study’s co-leader.

Additional sources: University of Edinburg via Science Daily

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUN 01, 2020
Cancer
A New RNA in Fine-Tuned Signal Regulation
JUN 01, 2020
A New RNA in Fine-Tuned Signal Regulation
In a healthy cell, many complex networks work to make sure everything runs as it should. Some of these networks function ...
JUN 22, 2020
Cancer
Black patients are underrepresented in clinical trials
JUN 22, 2020
Black patients are underrepresented in clinical trials
Amidst the swell of racial injustice that the country is bringing to light, new research reports that Black patients are ...
JUN 23, 2020
Cancer
Why are certain people more vulnerable to carcinogens?
JUN 23, 2020
Why are certain people more vulnerable to carcinogens?
A study from the University of Hawaii Cancer Center entitled, "Tumour predisposition and cancer syndromes as models ...
JUL 15, 2020
Cancer
Traditional Medicine Reveals a New Anti-Cancer Drug
JUL 15, 2020
Traditional Medicine Reveals a New Anti-Cancer Drug
The art of traditional eastern medicine dates back thousands of years. It uses many unproven remedies, and many consider ...
AUG 07, 2020
Cancer
Immune-Related Genes as Prognostic Biomarkers
AUG 07, 2020
Immune-Related Genes as Prognostic Biomarkers
Cancer is one of the most persistent and hardy diseases. Cancers often develop the ability to suppress the immune system ...
AUG 10, 2020
Cancer
A New Prognostic Biomarker for Paclitaxel Sensitivity in Breast Cancer
AUG 10, 2020
A New Prognostic Biomarker for Paclitaxel Sensitivity in Breast Cancer
Breast cancer is one of the deadliest cancers globally. It has been studied extensively with plenty of treatments availa ...
Loading Comments...